听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览GUT期刊下所有文献
  • Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial.

    abstract:OBJECTIVE:Patients with a history of Helicobacter pylori-negative idiopathic bleeding ulcers have a considerable risk of recurrent ulcer complications. We hypothesised that a proton pump inhibitor (lansoprazole) is superior to a histamine 2 receptor antagonist (famotidine) for the prevention of recurrent ulcer bleeding...

    journal_title:Gut

    pub_type: 杂志文章,随机对照试验

    doi:10.1136/gutjnl-2019-318715

    authors: Wong GLH,Lau LHS,Ching JYL,Tse YK,Ling RHY,Wong VWS,Chiu PWY,Lau JYW,Chan FKL

    更新日期:2020-04-01 00:00:00

  • Adeno-associated virus in the liver: natural history and consequences in tumour development.

    abstract:OBJECTIVE:Adeno-associated virus (AAV) is a defective mono-stranded DNA virus, endemic in human population (35%-80%). Recurrent clonal AAV2 insertions are associated with the pathogenesis of rare human hepatocellular carcinoma (HCC) developed on normal liver. This study aimed to characterise the natural history of AAV ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2019-318281

    authors: La Bella T,Imbeaud S,Peneau C,Mami I,Datta S,Bayard Q,Caruso S,Hirsch TZ,Calderaro J,Morcrette G,Guettier C,Paradis V,Amaddeo G,Laurent A,Possenti L,Chiche L,Bioulac-Sage P,Blanc JF,Letouze E,Nault JC,Zucman-Rossi

    更新日期:2020-04-01 00:00:00

  • Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for Helicobacter pylori: a territory-wide cohort study.

    abstract:OBJECTIVE:The risk of GI bleeding (GIB) in aspirin users after Helicobacter pylori (HP) eradication remains poorly defined. We characterised the incidences and temporal trends of hospitalisations for all GIB in aspirin users after HP eradication therapy. DESIGN:Based on a territory-wide health database, we identified ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2019-318352

    authors: Guo CG,Cheung KS,Zhang F,Chan EW,Chen L,Wong IC,Leung WK

    更新日期:2020-03-01 00:00:00

  • British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.

    abstract::These consensus guidelines were jointly commissioned by the British Society of Gastroenterology (BSG), the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and Public Health England (PHE). They provide an evidence-based framework for the use of surveillance colonoscopy and non-colonoscopic colorecta...

    journal_title:Gut

    pub_type: 杂志文章,实务指引

    doi:10.1136/gutjnl-2019-319858

    authors: Rutter MD,East J,Rees CJ,Cripps N,Docherty J,Dolwani S,Kaye PV,Monahan KJ,Novelli MR,Plumb A,Saunders BP,Thomas-Gibson S,Tolan DJM,Whyte S,Bonnington S,Scope A,Wong R,Hibbert B,Marsh J,Moores B,Cross A,Sharp L

    更新日期:2020-02-01 00:00:00

  • Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.

    abstract:BACKGROUND AND AIMS:Serrated polyposis syndrome (SPS) is associated with an increased risk of colorectal cancer (CRC). International guidelines recommend surveillance intervals of 1-2 years. However, yearly surveillance likely leads to overtreatment for many. We prospectively assessed a surveillance protocol aiming to ...

    journal_title:Gut

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1136/gutjnl-2018-318134

    authors: Bleijenberg AG,IJspeert JE,van Herwaarden YJ,Carballal S,Pellisé M,Jung G,Bisseling TM,Nagtegaal ID,van Leerdam ME,van Lelyveld N,Bessa X,Rodríguez-Moranta F,Bastiaansen B,de Klaver W,Rivero L,Spaander MC,Koornstra JJ,B

    更新日期:2020-01-01 00:00:00

  • Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.

    abstract:OBJECTIVE:The colonic inner mucus layer protects us from pathogens and commensal-induced inflammation, and has been shown to be defective in active UC. The aim of this study was to determine the underlying compositional alterations, their molecular background and potential contribution to UC pathogenesis. DESIGN:In th...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-317571

    authors: van der Post S,Jabbar KS,Birchenough G,Arike L,Akhtar N,Sjovall H,Johansson MEV,Hansson GC

    更新日期:2019-12-01 00:00:00

  • Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.

    abstract:OBJECTIVE:Current strategies to guide selection of neoadjuvant therapy in oesophageal adenocarcinoma (OAC) are inadequate. We assessed the ability of a DNA damage immune response (DDIR) assay to predict response following neoadjuvant chemotherapy in OAC. DESIGN:Transcriptional profiling of 273 formalin-fixed paraffin-...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-317624

    authors: Turkington RC,Knight LA,Blayney JK,Secrier M,Douglas R,Parkes EE,Sutton EK,Stevenson L,McManus D,Halliday S,McCavigan AM,Logan GE,Walker SM,Steele CJ,Perner J,Bornschein J,MacRae S,Miremadi A,McCarron E,McQuaid S,

    更新日期:2019-11-01 00:00:00

  • STING signalling protects against chronic pancreatitis by modulating Th17 response.

    abstract:OBJECTIVE:Chronic pancreatitis (CP) is an inflammatory disease with progressive fibrosis leading to exocrine and endocrine dysfunction. Currently, there are no approved effective therapies for CP. Stimulator of interferon genes (STING) signalling is a key innate immune sensor of DNA. In this study, we evaluated the rol...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-317098

    authors: Zhao Q,Manohar M,Wei Y,Pandol SJ,Habtezion A

    更新日期:2019-10-01 00:00:00

  • JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?

    abstract::The two major forms of inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic immune-mediated conditions characterised by an increased production of pro-inflammatory cytokines that act as critical drivers of intestinal inflammation. Anti-cytokine therapy has been s...

    journal_title:Gut

    pub_type: 杂志文章,评审

    doi:10.1136/gutjnl-2019-318448

    authors: Danese S,Argollo M,Le Berre C,Peyrin-Biroulet L

    更新日期:2019-10-01 00:00:00

  • International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis.

    abstract:OBJECTIVE:In this consensus statement, an international panel of experts deliver their opinions on key questions regarding the contribution of the human microbiome to carcinogenesis. DESIGN:International experts in oncology and/or microbiome research were approached by personal communication to form a panel. A structu...

    journal_title:Gut

    pub_type: 共识发展会议,杂志文章

    doi:10.1136/gutjnl-2019-318556

    authors: Scott AJ,Alexander JL,Merrifield CA,Cunningham D,Jobin C,Brown R,Alverdy J,O'Keefe SJ,Gaskins HR,Teare J,Yu J,Hughes DJ,Verstraelen H,Burton J,O'Toole PW,Rosenberg DW,Marchesi JR,Kinross JM

    更新日期:2019-09-01 00:00:00

  • RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours.

    abstract:OBJECTIVE:We aimed at the identification of genetic alterations that may functionally substitute for CTNNB1 mutation in ß-catenin-activated hepatocellular adenomas (HCAs) and hepatocellular carcinoma (HCC). DESIGN:Large cohorts of HCA (n=185) and HCC (n=468) were classified using immunohistochemistry. The mutational s...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-317632

    authors: Longerich T,Endris V,Neumann O,Rempel E,Kirchner M,Abadi Z,Uhrig S,Kriegsmann M,Weiss KH,Breuhahn K,Mehrabi A,Weber TF,Wilkens L,Straub BK,Rosenwald A,Schulze F,Brors B,Froehling S,Pellegrino R,Budczies J,Schirmac

    更新日期:2019-07-01 00:00:00

  • Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report.

    abstract:OBJECTIVE:To present comparative data about the performance of colorectal cancer (CRC) screening programmes in the European Union Member States (EU MSs). DESIGN:Cross-sectional study. We analysed key performance indicators-participation rate, positivity rate (PR), detection rate (DR) and positive predictive value for ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-317293

    authors: Senore C,Basu P,Anttila A,Ponti A,Tomatis M,Vale DB,Ronco G,Soerjomataram I,Primic-Žakelj M,Riggi E,Dillner J,Elfström MK,Lönnberg S,Sankaranarayanan R,Segnan N

    更新日期:2019-07-01 00:00:00

  • Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.

    abstract:OBJECTIVES:Patients with gallbladder carcinoma (GBC) lack effective treatment methods largely due to the inadequacy of both molecular characterisation and potential therapeutic targets. We previously uncovered a spectrum of genomic alterations and identified recurrent mutations in the ErbB pathway in GBC. Here, we aime...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-316039

    authors: Li M,Liu F,Zhang F,Zhou W,Jiang X,Yang Y,Qu K,Wang Y,Ma Q,Wang T,Bai L,Wang Z,Song X,Zhu Y,Yuan R,Gao Y,Liu Y,Jin Y,Li H,Xiang S,Ye Y,Zhang Y,Jiang L,Hu Y,Hao Y,Lu W,Chen S,Gu J,Zhou J,Gong W,Z

    更新日期:2019-06-01 00:00:00

  • Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.

    abstract:OBJECTIVE:To characterise gut microbiome in patients with hepatocellular carcinoma (HCC) and evaluate the potential of microbiome as non-invasive biomarkers for HCC. DESIGN:We collected 486 faecal samples from East China, Central China and Northwest China prospectively and finally 419 samples completed Miseq sequencin...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-315084

    authors: Ren Z,Li A,Jiang J,Zhou L,Yu Z,Lu H,Xie H,Chen X,Shao L,Zhang R,Xu S,Zhang H,Cui G,Chen X,Sun R,Wen H,Lerut JP,Kan Q,Li L,Zheng S

    更新日期:2019-06-01 00:00:00

  • Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review.

    abstract::Patients with Crohn's disease commonly develop ileal and less commonly colonic strictures, containing various degrees of inflammation and fibrosis. While predominantly inflammatory strictures may benefit from a medical anti-inflammatory treatment, predominantly fibrotic strictures currently require endoscopic balloon ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-318081

    authors: Bettenworth D,Bokemeyer A,Baker M,Mao R,Parker CE,Nguyen T,Ma C,Panés J,Rimola J,Fletcher JG,Jairath V,Feagan BG,Rieder F,Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium.

    更新日期:2019-06-01 00:00:00

  • Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.

    abstract:OBJECTIVE:Most colorectal cancer (CRC) screening programmes are nowadays based on faecal immunochemical testing (FIT). Eligible subjects often use oral anticoagulants (OACs) or non-steroidal anti-inflammatory drugs (NSAIDs), which could possibly stimulate bleeding from both benign and premalignant lesions in the colon....

    journal_title:Gut

    pub_type: 杂志文章,meta分析

    doi:10.1136/gutjnl-2018-316344

    authors: Nieuwenburg SAV,Vuik FER,Kruip MJHA,Kuipers EJ,Spaander MCW

    更新日期:2019-05-01 00:00:00

  • Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection.

    abstract:OBJECTIVE:Chronic HBV infection affects more than 250 million people worldwide and remains a global healthcare problem in part because we lack curative treatment. Sustained viral control requires HBV-specific T cells, but these become functionally impaired in chronic infection. Clinical evidence indicates that function...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-316644

    authors: Hoogeveen RC,Robidoux MP,Schwarz T,Heydmann L,Cheney JA,Kvistad D,Aneja J,Melgaço JG,Fernandes CA,Chung RT,Boonstra A,Kim AY,Baumert TF,Timm J,Lewis-Ximenez LL,Tonnerre P,Lauer GM

    更新日期:2019-05-01 00:00:00

  • Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.

    abstract:OBJECTIVE:Recent evidence suggesting an important role of gut-derived inflammation in brain disorders has opened up new directions to explore the possible role of the gut-brain axis in neurodegenerative diseases. Given the prominence of dysbiosis and colonic dysfunction in patients with Parkinson's disease (PD), we pro...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-316844

    authors: Perez-Pardo P,Dodiya HB,Engen PA,Forsyth CB,Huschens AM,Shaikh M,Voigt RM,Naqib A,Green SJ,Kordower JH,Shannon KM,Garssen J,Kraneveld AD,Keshavarzian A

    更新日期:2019-05-01 00:00:00

  • Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis.

    abstract:OBJECTIVE:Hepatitis D virus (HDV) is a defective virus that completes its life cycle only with hepatitis B virus (HBV). The HBV with HDV super-infection has been considered as one of the most severe forms of the chronic viral hepatitis. However, there is a scarcity of data on the global burden of HDV infection. DESIGN...

    journal_title:Gut

    pub_type: 杂志文章,meta分析

    doi:10.1136/gutjnl-2018-316601

    authors: Chen HY,Shen DT,Ji DZ,Han PC,Zhang WM,Ma JF,Chen WS,Goyal H,Pan S,Xu HG

    更新日期:2019-03-01 00:00:00

  • Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage.

    abstract:OBJECTIVE:Liver injury impacts hepatic inflammation in part via Toll-like receptor (TLR) signalling. Triggering receptor expressed on myeloid cells 2 (TREM-2) modulates TLR4-mediated inflammation in bone marrow (BM)-derived macrophages but its function in liver injury is unknown. Here we hypothesised that the anti-infl...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-314107

    authors: Perugorria MJ,Esparza-Baquer A,Oakley F,Labiano I,Korosec A,Jais A,Mann J,Tiniakos D,Santos-Laso A,Arbelaiz A,Gawish R,Sampedro A,Fontanellas A,Hijona E,Jimenez-Agüero R,Esterbauer H,Stoiber D,Bujanda L,Banales JM,K

    更新日期:2019-03-01 00:00:00

  • Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis.

    abstract:OBJECTIVE:Opioids are increasingly prescribed in the West and have deleterious GI consequences. Pharmacological therapies to treat opioid-induced constipation (OIC) are available, but their relative efficacy is unclear. We performed a systematic review and network meta-analysis to address this deficit in current knowle...

    journal_title:Gut

    pub_type: 杂志文章,meta分析

    doi:10.1136/gutjnl-2018-316001

    authors: Luthra P,Burr NE,Brenner DM,Ford AC

    更新日期:2019-03-01 00:00:00

  • Multiple balloon-like lesions in the small intestine of an adult with chronic diarrhoea.

    abstract:CLINICAL PRESENTATION:A 28-year-old woman presented with a 3-year history of chronic watery diarrhoea along with abdominal pain and bloating, which could mostly be alleviated after defecation. Her symptom of diarrhoea, at least three times a day, could be relieved by neither probiotics nor antidiarrhoeal agents. She ha...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2018-316182

    authors: Zhou CB,Lu H,Chen YX,Fang JY

    更新日期:2019-03-01 00:00:00

  • An Asian consensus on standards of diagnostic upper endoscopy for neoplasia.

    abstract:BACKGROUND:This is a consensus developed by a group of expert endoscopists aiming to standardise the preparation, process and endoscopic procedural steps for diagnosis of early upper gastrointestinal (GI) cancers. METHOD:The Delphi method was used to develop consensus statements through identification of clinical ques...

    journal_title:Gut

    pub_type: 共识发展会议,杂志文章

    doi:10.1136/gutjnl-2018-317111

    authors: Chiu PWY,Uedo N,Singh R,Gotoda T,Ng EKW,Yao K,Ang TL,Ho SH,Kikuchi D,Yao F,Pittayanon R,Goda K,Lau JYW,Tajiri H,Inoue H

    更新日期:2019-02-01 00:00:00

  • SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.

    abstract:OBJECTIVE:To investigate the molecular function of splicing factor SRSF6 in colorectal cancer (CRC) progression and discover candidate chemicals for cancer therapy through targeting SRSF6. DESIGN:We performed comprehensive analysis for the expression of SRSF6 in 311 CRC samples, The Cancer Genome Atlas and Gene Expres...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-314983

    authors: Wan L,Yu W,Shen E,Sun W,Liu Y,Kong J,Wu Y,Han F,Zhang L,Yu T,Zhou Y,Xie S,Xu E,Zhang H,Lai M

    更新日期:2019-01-01 00:00:00

  • Yellowish lesions in the oesophagus.

    abstract::CLINICAL PRESENTATION: A 51-year-old man, who had no previous disease, underwent a screening oesophagogastroduodenoscopy, which revealed multiple yellowish lesions in the middle thoracic oesophagus. All lesions were ≤3 mm in size and slightly elevated. Each lesion showed one or two white protrusions on the surface (fi...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-315700

    authors: Hamada K,Yamasaki Y,Kubota JI,Okada H

    更新日期:2019-01-01 00:00:00

  • Age-dependent changes in GI physiology and microbiota: time to reconsider?

    abstract::Our life expectancy is increasing, leading to a rise in the ageing population. Ageing is associated with a decline in physiological function and adaptive capacity. Altered GI physiology can affect the amount and types of nutrients digested and absorbed as well as impact the intestinal microbiota. The intestinal microb...

    journal_title:Gut

    pub_type: 杂志文章,评审

    doi:10.1136/gutjnl-2017-315542

    authors: An R,Wilms E,Masclee AAM,Smidt H,Zoetendal EG,Jonkers D

    更新日期:2018-12-01 00:00:00

  • Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.

    abstract:BACKGROUND:The long-term performance of colorectal cancer (CRC) screening programmes based on a 2-year faecal immunochemical test (FIT) is still unclear. METHODS:In a sample of 50 to 69-year-olds repeatedly screened with the FIT (OC-Hemodia latex agglutination test; cut-off: 20 µg haemoglobin/g faeces), we examined: (...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-314753

    authors: Zorzi M,Hassan C,Capodaglio G,Fedato C,Montaguti A,Turrin A,Rosano A,Monetti D,Stocco C,Baracco S,Russo F,Repici A,Rugge M

    更新日期:2018-12-01 00:00:00

  • A comparison of the resection rate for cold and hot snare polypectomy for 4-9 mm colorectal polyps: a multicentre randomised controlled trial (CRESCENT study).

    abstract:OBJECTIVE:To investigate the success rate of cold snare polypectomy (CSP) for complete resection of 4-9 mm colorectal adenomatous polyps compared with that of hot snare polypectomy (HSP). DESIGN:A prospective, multicentre, randomised controlled, parallel, non-inferiority trial conducted in 12 Japanese endoscopy units....

    journal_title:Gut

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1136/gutjnl-2017-314215

    authors: Kawamura T,Takeuchi Y,Asai S,Yokota I,Akamine E,Kato M,Akamatsu T,Tada K,Komeda Y,Iwatate M,Kawakami K,Nishikawa M,Watanabe D,Yamauchi A,Fukata N,Shimatani M,Ooi M,Fujita K,Sano Y,Kashida H,Hirose S,Iwagami H,

    更新日期:2018-11-01 00:00:00

  • Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis.

    abstract:BACKGROUND AND AIMS:Extrahepatic manifestations of HCV are responsible for morbidity and mortality in many chronically infected patients. New, interferon-free antiviral treatment regimens, which present the opportunity to treat all HCV-infected patients, call for a better understanding of the benefits of treating non-c...

    journal_title:Gut

    pub_type: 杂志文章,meta分析

    doi:10.1136/gutjnl-2018-316234

    authors: Cacoub P,Desbois AC,Comarmond C,Saadoun D

    更新日期:2018-11-01 00:00:00

  • NAD metabolism fuels human and mouse intestinal inflammation.

    abstract:OBJECTIVE:Nicotinamide phosphoribosyltransferase (NAMPT, also referred to as pre-B cell colony-enhancing factor or visfatin) is critically required for the maintenance of cellular nicotinamide adenine dinucleotide (NAD) supply catalysing the rate-limiting step of the NAD salvage pathway. NAMPT is strongly upregulated i...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-314241

    authors: Gerner RR,Klepsch V,Macheiner S,Arnhard K,Adolph TE,Grander C,Wieser V,Pfister A,Moser P,Hermann-Kleiter N,Baier G,Oberacher H,Tilg H,Moschen AR

    更新日期:2018-10-01 00:00:00

  • Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study.

    abstract:OBJECTIVE:This phase II, randomised, double-blind, placebo-controlled clinical trial was designed to evaluate the efficacy and safety of PF-00547659, a fully human monoclonal antibody that binds to human mucosal addressin cell adhesion molecule (MAdCAM) to selectively reduce lymphocyte homing to the intestinal tract, i...

    journal_title:Gut

    pub_type: 杂志文章,随机对照试验

    doi:10.1136/gutjnl-2016-313457

    authors: Sandborn WJ,Lee SD,Tarabar D,Louis E,Klopocka M,Klaus J,Reinisch W,Hébuterne X,Park DI,Schreiber S,Nayak S,Ahmad A,Banerjee A,Brown LS,Cataldi F,Gorelick KJ,Cheng JB,Hassan-Zahraee M,Clare R,D'Haens GR

    更新日期:2018-10-01 00:00:00

  • Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence.

    abstract:OBJECTIVE:In association with innate and adaptive immunity, the microbiota controls the colonisation resistance against intestinal pathogens. Caspase recruitment domain 9 (CARD9), a key innate immunity gene, is required to shape a normal gut microbiota. Card9-/- mice are more susceptible to the enteric mouse pathogen C...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-314195

    authors: Lamas B,Michel ML,Waldschmitt N,Pham HP,Zacharioudaki V,Dupraz L,Delacre M,Natividad JM,Costa GD,Planchais J,Sovran B,Bridonneau C,Six A,Langella P,Richard ML,Chamaillard M,Sokol H

    更新日期:2018-10-01 00:00:00

  • Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.

    abstract:OBJECTIVE:As the current therapeutic strategies for human hepatocellular carcinoma (HCC) have been proven to have limited effectiveness, immunotherapy becomes a compelling way to tackle the disease. We aim to provide humanised mouse (humice) models for the understanding of the interaction between human cancer and immun...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-315201

    authors: Zhao Y,Shuen TWH,Toh TB,Chan XY,Liu M,Tan SY,Fan Y,Yang H,Lyer SG,Bonney GK,Loh E,Chang KTE,Tan TC,Zhai W,Chan JKY,Chow EK,Chee CE,Lee GH,Dan YY,Chow PK,Toh HC,Lim SG,Chen Q

    更新日期:2018-10-01 00:00:00

  • Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas.

    abstract:OBJECTIVES:Oesophageal squamous cell carcinoma (OSCC) and adenocarcinoma (OAC) are distinct cancers in terms of a number of clinical and epidemiological characteristics, complicating the design of clinical trials and biomarker developments. We analysed 1048 oesophageal tumour-germline pairs from both subtypes, to chara...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-314607

    authors: Lin DC,Dinh HQ,Xie JJ,Mayakonda A,Silva TC,Jiang YY,Ding LW,He JZ,Xu XE,Hao JJ,Wang MR,Li C,Xu LY,Li EM,Berman BP,Phillip Koeffler H

    更新日期:2018-10-01 00:00:00

  • Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.

    abstract:OBJECTIVE:Hippo signalling is a recently identified major oncosuppressive pathway that plays critical roles in inhibiting hepatocyte proliferation, survival and hepatocellular carcinoma (HCC) formation. Hippo kinase (Mst1 and Mst2) inhibits HCC proliferation by suppressing Yap/Taz transcription activities. As human HCC...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-314061

    authors: Kim W,Khan SK,Liu Y,Xu R,Park O,He Y,Cha B,Gao B,Yang Y

    更新日期:2018-09-01 00:00:00

  • The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

    abstract::Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and progressive fibrosis can culminate over time in an end-stage biliary cirrhosis. Both genetic and environmental influences are...

    journal_title:Gut

    pub_type: 指南,杂志文章,实务指引

    doi:10.1136/gutjnl-2017-315259

    authors: Hirschfield GM,Dyson JK,Alexander GJM,Chapman MH,Collier J,Hübscher S,Patanwala I,Pereira SP,Thain C,Thorburn D,Tiniakos D,Walmsley M,Webster G,Jones DEJ

    更新日期:2018-09-01 00:00:00

  • CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.

    abstract:OBJECTIVE:Metabolic reprogramming of tumour cells that allows for adaptation to their local environment is a hallmark of cancer. Interestingly, obesity-driven and non-alcoholic steatohepatitis (NASH)-driven hepatocellular carcinoma (HCC) mouse models commonly exhibit strong steatosis in tumour cells as seen in human st...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-315193

    authors: Fujiwara N,Nakagawa H,Enooku K,Kudo Y,Hayata Y,Nakatsuka T,Tanaka Y,Tateishi R,Hikiba Y,Misumi K,Tanaka M,Hayashi A,Shibahara J,Fukayama M,Arita J,Hasegawa K,Hirschfield H,Hoshida Y,Hirata Y,Otsuka M,Tateishi K,

    更新日期:2018-08-01 00:00:00

  • High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.

    abstract:OBJECTIVE:A high body mass index (BMI) is associated with an increased risk for severe liver disease. It is unclear if this risk differs across BMI categories, and if the association is partially attributed to development of type 2 diabetes mellitus (T2DM). DESIGN:We used register data from more than 1.2 million Swedi...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2016-313622

    authors: Hagström H,Tynelius P,Rasmussen F

    更新日期:2018-08-01 00:00:00

  • Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.

    abstract:OBJECTIVE:Gastric cancer is the third leading cause of cancer death worldwide and infection by Helicobacter pylori is the strongest risk factor. We have reported increased epidermal growth factor receptor (EGFR) phosphorylation in the H. pylori-induced human carcinogenesis cascade, and association with DNA damage. Our ...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2016-312888

    authors: Sierra JC,Asim M,Verriere TG,Piazuelo MB,Suarez G,Romero-Gallo J,Delgado AG,Wroblewski LE,Barry DP,Peek RM Jr,Gobert AP,Wilson KT

    更新日期:2018-07-01 00:00:00

  • Differential preventive activity of sulindac and atorvastatin in Apc+/Min-FCCCmice with or without colorectal adenomas.

    abstract:OBJECTIVE:The response of subjects to preventive intervention is heterogeneous. The goal of this study was to determine if the efficacy of a chemopreventive agent differs in non-tumour-bearing animals versus those with colorectal tumours. Sulindac and/or atorvastatin was administered to Apc+/Min-FCCC mice with known tu...

    journal_title:Gut

    pub_type: 杂志文章

    doi:10.1136/gutjnl-2017-313942

    authors: Chang WL,Jackson C,Riel S,Cooper HS,Devarajan K,Hensley HH,Zhou Y,Vanderveer LA,Nguyen MT,Clapper ML

    更新日期:2018-07-01 00:00:00

1152 条记录 2/29 页 « 12345678...2829 »